LobbyingFrontier Pharmaceuticals lobbying by quarter
Frontier Pharmaceuticals's latest lobbying report covers Q3 2025, at $30K. Its first report covers Q2 2025; the issues it reports most are Budget/Appropriations and Defense.
Frontier Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $30K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$20K · 2 reports
- Defense$20K · 2 reports
- Health issues$20K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| McAllister & Quinn | $60K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ANDREW QUINN | SA, LA - Rep. Hoyer | Q3 2025 |
| BRANDON REA | LI - Rep. Cuellar | Q3 2025 |
| ELIZABETH FOLEY | LA - Rep. McCollum | Q3 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 01/20for Q3 2025 | McAllister & Quinn | $30K |
| 25/10/14for Q3 2025 | McAllister & Quinn | $30K |
| 25/07/21for Q2 2025 | McAllister & Quinn | $30K |
| 25/07/21for Q2 2025 | McAllister & Quinn | Under $5,000 |